Diastolic heart failure (HF) accounts for up to 50% of all HF admissions with hypertension being 31 the major cause of diastolic HF. Hypertension is characterized by left ventricular (LV) 32 hypertrophy (LVH). Pro-inflammatory cytokines are increased in LVH and hypertension but it is 33 unknown if they mediate the progression of hypertension-induced diastolic HF. We sought to 34 determine if IFNγ plays a role in mediating the transition from hypertension-induced LVH to 35 diastolic HF. Twelve-week old BALB/c (WT) and IFNγ deficient (IFNγKO) mice underwent 36 either saline-(n=12) or aldosterone-infusion (n=16), uninephrectomy and fed 1% salt water for 37 4-weeks. Tail-cuff blood pressure, echocardiography and gene/protein analyses were performed. 38
10.

H-Leucine Incorporation.
3 H-leucine incorporation was measured over the final hours of a 24-hour period of aldosterone treatment described previously (10). The activity of Table) . As expected, chronic aldosterone increased LV mass 209 (measured by echocardiography) in WT mice. However LV mass was greater in aldosterone mice over the 4-weeks ( Fig. 1B; P<0.05) . Similarly LV/ body weight (BW) ratio 211 increased in WT-aldosterone (4.3±0.1) and was more marked in IFNγKO-aldosterone mice 212 (4.9±0.1; P<0.001 vs. WT-aldosterone). Chronic aldosterone increased cardiomyocyte cross-213 sectional area in WT-aldosterone but was greater in IFNγKO-aldosterone hearts (P<0.05; Table) .
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HR was lower in both groups of aldosterone infused mice but was no different between 215 WT and IFNγ mice. BW was comparable between all groups of mice. Chronic aldosterone 216 increased pulmonary congestion (as measured by wet-to-dry lung ratio) but no different between 217 WT and IFNγ aldosterone-infused mice (Table) . 218
Mice lacking IFNγ had smaller LV cavity size ( Figs. 2A-D) . In WT mice, chronic 219 aldosterone had negligible effects on LV end diastolic dimensions (LVEDD) and end systolic 220 dimensions (LVESD) vs. WT-saline mice (3.5±0.4 vs. 3.4±0.2 mm and 2.1±0.1 vs. 1.8±0.2 mm, 221 respectively). However, aldosterone infusion in IFNγKO mice, significantly decreased LVESD 222
(1.1±0.1 mm) vs. WT-aldosterone mice. LVEDD was unchanged. LV ejection fraction (EF) was 223 within the normal range but significantly increased in IFNγKO-aldosterone vs. WT-aldosterone 224 hearts (81±2% vs. 70±2%). Total wall thickness (TWT) was greater in IFNγKO-aldosterone than 225
WT-aldosterone mice (1.4±0.1 vs. 1.2±0.1 mm; P<0.05). There was no intracavitary gradient or 226
obstruction. 227
Mice lacking IFNγ had more severe diastolic dysfunction. As in our prior studies (20; 228 34; 50) , chronic aldosterone caused diastolic HF (defined as preserved LV EF with pulmonary 229 congestion) in both WT and IFNγKO mice (Table, Fig. 2D ). There was evidence of aldosterone-230 induced LV diastolic dysfunction using both hemodynamic monitoring and Doppler 231 echocardiography (Table) . Peak rates of LV pressure development (LV dP/dt max ) increased with 232 aldosterone infusion in both WT and IFNγKO mice indicating improved LV contractile function. 233 LV dp/dt min in the IFNγKO-aldosterone mice was significantly less negative compared to 234 12.
(LV dp/dt min ) and increased LV EDP suggested worse diastolic dysfunction in aldosterone than WT-aldosterone mice. Similarly mitral valve inflow velocity (with Doppler 239 echocardiography) also showed impaired diastolic function in IFNγKO-aldosterone mice 240 (Table) . Because normal physiological HRs in mice are rapid (>600bpm) and results in the loss 241 of the A-velocity by Doppler (41), these measurements were made at comparable (although non-242 physiological) HRs using isoflurane which lowered HRs to comparable levels (~350bpm) to 243 control for loading conditions (41). In sedated mice HR were lowered in all 4 groups and were 244 no different (Table) . In WT mice, aldosterone significantly increased mitral E velocity by 245 55±2% (early diastolic filling velocity) whilst there was minimal change in mitral A wave 246 velocity (late diastolic filling). The resultant E/A ratio (2.8±0.1) was increased in WT-247 aldosterone mice, indicating reduced LV compliance (increased LV stiffness). Aldosterone also 248 significantly increased mitral E velocity by 75±5% in IFNγKO mice. The resultant E/A ratio 249 (3.1±0.1) -a measure of diastolic dysfunction, was greater in IFNγKO-aldosterone than WT-250 aldosterone hearts (P<0.05). Similar to humans, the increased E/A ratio suggests a restrictive 251 mitral inflow velocity profile. Deceleration time (DT) was non-significantly shortened consistent 252 with the elevated E/A ratio and diastolic dysfunction in both groups of aldosterone-infused 253 hearts. Aldosterone caused prolongation of isovolumetric relaxation time (IVRT) (Figs. 4D-F) . We previously showed that aldosterone increases myocardial TNF-α and 286 IFNγ (250 U/ml) alone had no effect on both benefits in hypertensive heart disease (37). In our study the lower BP in the IFNγKO-aldosterone 338 mice at the end of 4-weeks initially suggested that rIFNγ repletion might raise BP. On the 339 contrary there was no effect on BP, thus raising the possibility that the elevated BP and LVH 340 seen in the IFNγKO-aldosterone mice might not be temporally related. Diastolic dysfunction, 341 like LVH (21), may be an intermediary between hypertension and diastolic HF (40) and an 342 independent risk factor for HF and cardiovascular death (3). Similar to a human study by 343
IFN
Watchell et al. (46), we previously showed that independent of blood pressure, increased LVH 344 was associated with worsening of diastolic dysfunction. In the present study, the development of 345 induced diastolic HF the greatest myocardial expression of autophagic proteins was seen in 373 IFNγKO mice, but was noticeable for the lack of expression of the anti-inflammatory, IL-10 and 374 the pro-inflammatory cytokine, TNF-α. Although IFNγ has been shown to induce autophagy 375 (15), we show that IFNγ inhibits aldosterone-induced LC3-II expression in cardiac myocytes. 376 IFNγ, produced mainly by NK and T cells, stimulates Th1 T-cell development, activates 377 macrophages, and is pro-inflammatory. However, IFN-γ has been shown to suppress 378 inflammation in animal models of autoimmune disease (2). Even as basal levels of autophagy 379 function to maintain cell homeostasis, autophagy can be rapidly increased in response to stress or 380 elevated levels of ROS induced by aldosterone-induced diastolic HF. Our lab has shown that 381 aldosterone induces ROS in cardiomyocytes (33) and increasing amounts of ROS may activate 382 signaling pathways that lead to autophagic-induced cell death (19). Similarly elevated ROS can 383 contribute to p62 induction and cell damage (13). P62 interacts with LC3 and this interaction is 384 required for recruiting autophagosomes thus leading to autophagy (30). P62 expression has been 385 shown to be downregulated during autophagy (17), but recently, similar to our findings, p62 was 386 transcriptionally upregulated in hearts that overexpress misfolded proteins (53) and acts as a 387 central player in regulating . Similarly p62 increases LC3-II in 388 cardiomyocytes (53). P62 expression suggests that oxidative stress plays a role in diastolic HF 389 but may not play a role in the worsening of structural remodeling and diastolic dysfunction in 390 aldosterone-infused IFNγKO mice. 391
Although LVH and diastolic dysfunction were more impaired in IFNγKO-aldosterone 392 mice -possibly a restrictive pattern, it is unknown if the severe diastolic dysfunction is a 393 reversible or fixed restrictive pattern. Diastolic HF was no different between both groups of 394 aldosterone mice. It is possible that if mice were followed for a longer duration they may have19. developed worsening of diastolic HF i.e., LVH and diastolic dysfunction precede the 396 development of diastolic HF. It is also possible that diastolic dysfunction and LVH are 397 independent of diastolic HF and does not lead to diastolic HF. In the human Irbesartan in 398
HFpEF trial (I-PRESERVE), structural remodeling (59% had LVH) and diastolic dysfunction 399 (69%) was present in the majority of patients with diastolic HF also known as "HF with 400 preserved EF" (HFpEF) (56). Structural remodeling and diastolic dysfunction predicted adverse 401 clinical outcomes in HFpEF. Our data suggest that reversing structural remodeling and 402 improving function may improve outcomes and could reduce morbidity and mortality in HFpEF 403 patients. Taken together, the finding that IFNγ is as a regulator of cardiomyocyte hypertrophy 404 serves to enhance our understanding of the pathophysiology underlying diastolic heart failure (or 405 HFpEF), possibly via the regulation of autophagy. 406
Limitations: Firstly, our findings do not suggest a causal relationship between cytokines 407 and autophagy and will require further investigation. There is cross-talk between pro-death 408 pathways and we did not explore the role of IFNγ in apoptosis and autophagy. Secondly, 409 although IFNγ inhibits cardiomyocyte hypertrophy, the reduction in LC3-II expression may be 410 an epiphenomenon and simply reflect the reduction in hypertrophy. We did not explore the 411 mechanisms by which IFNγ modulates cardiomyocyte hypertrophy. Potential mechanisms 412 include nitric oxide independent mechanisms as seen in the inhibition of PGF 2α -induced cardiac 413 hypertrophy (18). Additional pathways will be explored in future studies. Increased LC3 414 expression suggests that autophagy contributes to hypertension-induced cardiac remodeling. 415
Whether this is a pro-survival response or one that contributes to clinical decompensation likely 416 depends on the level of stress in the pathologic setting. Thirdly, the normal physiological HR in 417 mice is rapid (>600bpm) and results in the loss of the A-velocity by echocardiography (41; 52),20.
thus in order to measure diastolic function parameters specifically A-velocity (late diastolic 419 filling) all groups of mice were subjected to lower, but non-physiological, HR as we described 420 previously (34; 50). Although others have shown comparable anesthesia-induced hemodynamic 421 changes (16; 47), our measurements were standardized at lower and comparable HR for all 4 422 groups of mice. Finally, alterations in the vasculature and the kidney are evident in both human 423 and experimental diastolic HF (34; 50). We did not determine if these extra-cardiac changes 424
were altered with IFNγ deficiency in diastolic HF. 425
In conclusion, deficiency in IFNγ increases structural remodeling, diastolic dysfunction 426 and diastolic HF suggesting that Th1 cytokines play a beneficial role in hypertension-induced 427 diastolic HF. This is associated with autophagy which may be an important effector of Th1/Th2 428 polarization. IFNγ modulates aldosterone-induced cardiac hypertrophy independent of blood 429 pressure. These findings challenge the concept that all inflammatory cytokines are deleterious. 
